Showing 1 - 3 of 3 trials – Showing only trials currently accepting patients

• Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid Tumors

  Stanford is currently accepting patients for this trial.

• Trial of Acebilustat for the Treatment of Upper Arm Lymphedema

  Stanford is currently accepting patients for this trial.

• Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

  Stanford is currently accepting patients for this trial.